Logo image of ALIKO.PA

IKONISYS SA (ALIKO.PA) Stock Fundamental Analysis

Europe - EPA:ALIKO - FR00140048X2 - Common Stock

1.425 EUR
-0.03 (-2.4%)
Last: 11/6/2025, 7:00:00 PM
Fundamental Rating

1

Taking everything into account, ALIKO scores 1 out of 10 in our fundamental rating. ALIKO was compared to 60 industry peers in the Health Care Equipment & Supplies industry. ALIKO may be in some trouble as it scores bad on both profitability and health. ALIKO is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ALIKO had negative earnings in the past year.
In the past year ALIKO has reported a negative cash flow from operations.
In the past 5 years ALIKO always reported negative net income.
ALIKO had a negative operating cash flow in each of the past 5 years.
ALIKO.PA Yearly Net Income VS EBIT VS OCF VS FCFALIKO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -500K -1M -1.5M -2M

1.2 Ratios

The Return On Assets of ALIKO (-10.87%) is worse than 70.00% of its industry peers.
The Return On Equity of ALIKO (-14.41%) is worse than 68.33% of its industry peers.
Industry RankSector Rank
ROA -10.87%
ROE -14.41%
ROIC N/A
ROA(3y)-8.23%
ROA(5y)-11.93%
ROE(3y)-10.37%
ROE(5y)-15.89%
ROIC(3y)N/A
ROIC(5y)N/A
ALIKO.PA Yearly ROA, ROE, ROICALIKO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 -10 -20

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ALIKO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALIKO.PA Yearly Profit, Operating, Gross MarginsALIKO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -200 -400

More info and screens

1

2. Health

2.1 Basic Checks

ALIKO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALIKO has more shares outstanding
The debt/assets ratio for ALIKO is higher compared to a year ago.
ALIKO.PA Yearly Shares OutstandingALIKO.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2M 4M 6M 8M
ALIKO.PA Yearly Total Debt VS Total AssetsALIKO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

ALIKO has an Altman-Z score of 1.49. This is a bad value and indicates that ALIKO is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.49, ALIKO is doing worse than 65.00% of the companies in the same industry.
ALIKO has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
ALIKO's Debt to Equity ratio of 0.10 is fine compared to the rest of the industry. ALIKO outperforms 76.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 1.49
ROIC/WACCN/A
WACC7.78%
ALIKO.PA Yearly LT Debt VS Equity VS FCFALIKO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 5M 10M 15M 20M

2.3 Liquidity

A Current Ratio of 0.20 indicates that ALIKO may have some problems paying its short term obligations.
The Current ratio of ALIKO (0.20) is worse than 95.00% of its industry peers.
A Quick Ratio of 0.06 indicates that ALIKO may have some problems paying its short term obligations.
With a Quick ratio value of 0.06, ALIKO is not doing good in the industry: 95.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.2
Quick Ratio 0.06
ALIKO.PA Yearly Current Assets VS Current LiabilitesALIKO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 1M 2M 3M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for ALIKO have decreased by -6.92% in the last year.
The Revenue has grown by 14.59% in the past year. This is quite good.
The Revenue has been growing slightly by 5.20% on average over the past years.
EPS 1Y (TTM)-6.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-34.48%
Revenue 1Y (TTM)14.59%
Revenue growth 3Y5.2%
Revenue growth 5YN/A
Sales Q2Q%130.8%

3.2 Future

ALIKO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.29% yearly.
The Revenue is expected to grow by 72.46% on average over the next years. This is a very strong growth
EPS Next Y-32.5%
EPS Next 2Y2.47%
EPS Next 3Y13.67%
EPS Next 5Y29.29%
Revenue Next Year0%
Revenue Next 2Y41.42%
Revenue Next 3Y91.29%
Revenue Next 5Y72.46%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALIKO.PA Yearly Revenue VS EstimatesALIKO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10M 20M 30M
ALIKO.PA Yearly EPS VS EstimatesALIKO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 -0.2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALIKO. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALIKO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALIKO.PA Price Earnings VS Forward Price EarningsALIKO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALIKO.PA Per share dataALIKO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

ALIKO's earnings are expected to grow with 13.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.47%
EPS Next 3Y13.67%

More info and screens

0

5. Dividend

5.1 Amount

ALIKO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IKONISYS SA

EPA:ALIKO (11/6/2025, 7:00:00 PM)

1.425

-0.03 (-2.4%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners51.65%
Inst Owner ChangeN/A
Ins Owners2.51%
Ins Owner ChangeN/A
Market Cap19.98M
Revenue(TTM)617.20K
Net Income(TTM)-2.27M
Analysts86.67
Price Target2.86 (100.7%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-31.71%
PT rev (3m)-31.71%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-13.98%
EPS NY rev (3m)-13.98%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 44.54
P/FCF N/A
P/OCF N/A
P/B 1.27
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.27
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.03
BVpS1.12
TBVpS-0.31
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.87%
ROE -14.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-8.23%
ROA(5y)-11.93%
ROE(3y)-10.37%
ROE(5y)-15.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.2
Quick Ratio 0.06
Altman-Z 1.49
F-Score2
WACC7.78%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-34.48%
EPS Next Y-32.5%
EPS Next 2Y2.47%
EPS Next 3Y13.67%
EPS Next 5Y29.29%
Revenue 1Y (TTM)14.59%
Revenue growth 3Y5.2%
Revenue growth 5YN/A
Sales Q2Q%130.8%
Revenue Next Year0%
Revenue Next 2Y41.42%
Revenue Next 3Y91.29%
Revenue Next 5Y72.46%
EBIT growth 1Y9.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year44.44%
EBIT Next 3Y25.99%
EBIT Next 5Y32.55%
FCF growth 1Y20.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.63%
OCF growth 3YN/A
OCF growth 5YN/A

IKONISYS SA / ALIKO.PA FAQ

What is the ChartMill fundamental rating of IKONISYS SA (ALIKO.PA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to ALIKO.PA.


What is the valuation status of IKONISYS SA (ALIKO.PA) stock?

ChartMill assigns a valuation rating of 0 / 10 to IKONISYS SA (ALIKO.PA). This can be considered as Overvalued.


What is the profitability of ALIKO stock?

IKONISYS SA (ALIKO.PA) has a profitability rating of 0 / 10.